Released Mar 1, 2013, during market hours
10-K filed Mar 1, 2013, 60 days after period end · 0001193125-13-087561
Q4 2012 · 10-K
Revenue$115.61M$115.61M −2.6% vs Q4 2011+9.3% vs Q3 2012
Net Income$22.95M$22.95M +191.0% vs Q4 2011+512.6% vs Q3 2012
EPS Diluted$1.17$1.17 +178.6% vs Q4 2011+515.8% vs Q3 2012
Gross Profit$88,856,000−2.7%
Operating Income$26,518,000+224.4%
Operating Cash Flowderived-$58,233,000N/M
Free Cash Flowderived-$68,015,000N/M
Margins · derived
Gross margin76.9%−0.1 pt vs Q4 2011
Operating margin22.9%+16.0 pt vs Q4 2011
Net margin19.9%+13.2 pt vs Q4 2011
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2012 | Q4 2011 | Q4 2010 |
|---|---|---|---|
| Revenue | $115.61M | $118.64M | $143.80M |
| Net Income | $22.95M | $7.89M | $7.96M |
| EPS Diluted | $1.17 | $0.42 | $0.44 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR